• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Researchers use AI to track cognitive deviation in aging brains

Bioengineer by Bioengineer
June 23, 2021
in Science News
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Radiological Society of North America

OAK BROOK, Ill. – Researchers have developed an artificial intelligence (AI)-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment, according to a study published in Radiology: Artificial Intelligence. The model has the potential to aid in early detection of cognitive impairment at an individual level.

Amnestic mild cognitive impairment (aMCI) is a transition phase from normal aging to Alzheimer’s disease (AD). People with aMCI have memory deficits that are more serious than normal for their age and education, but not severe enough to affect daily function.

For the study, Ni Shu, Ph.D., from State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, in Beijing, China, and colleagues used a machine learning approach to train a brain age prediction model based on the T1-weighted MR images of 974 healthy adults aged from 49.3 to 95.4 years. The trained model was applied to estimate the predicted age difference (predicted age vs. actual age) of aMCI patients in the Beijing Aging Brain Rejuvenation Initiative (616 healthy controls and 80 aMCI patients) and the Alzheimer’s Disease Neuroimaging Initiative (589 healthy controls and 144 aMCI patients) datasets.

The researchers also examined the associations between the predicted age difference and cognitive impairment, genetic risk factors, pathological biomarkers of AD, and clinical progression in aMCI patients.

The results showed that aMCI patients had brain-aging trajectories distinct from the typical normal aging trajectory, and the proposed brain age prediction model could quantify individual deviations from the typical normal aging trajectory in these patients. The predicted age difference was significantly associated with individual cognitive impairment of aMCI patients in several domains, specifically including memory, attention and executive function.

“The predictive model we generated was highly accurate at estimating chronological age in healthy participants based on only the appearance of MRI scans,” the researchers wrote. “In contrast, for aMCI, the model estimated brain age to be greater than 2.7 years older on average than the patient’s chronological age.”

The model further showed that progressive aMCI patients exhibit more deviations from typical normal aging than stable aMCI patients, and the use of the predicted age difference score along with other AD-specific biomarkers could better predict the progression of aMCI. Apolipoprotein E (APOE) ε4 carriers showed larger predicted age differences than non-carriers, and amyloid-positive patients showed larger predicted age differences than amyloid-negative patients.

Combining the predicted age difference with other biomarkers of AD showed the best performance in differentiating progressive aMCI from stable aMCI.

“This work indicates that predicted age difference has the potential to be a robust, reliable and computerized biomarker for early diagnosis of cognitive impairment and monitoring response to treatment,” the authors concluded.

###

“Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease and Clinical Progression.” Weijie Huang, Xin Li, He Li, Wenxiao Wang, Kewei Chen, Kai Xu, Junying Zhang, Yaojing Chen, Dongfeng Wei, Ni Shu, Ph.D., and Zhanjun Zhang.

Radiology: Artificial Intelligence is edited by Charles E. Kahn Jr., M.D., M.S., Perelman School of Medicine at the University of Pennsylvania, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/ai)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)

For information on brain MRI and Alzheimer’s Disease, visit RadiologyInfo.org.

Media Contact
Linda Brooks
[email protected]

Tags: AgingDiagnosticsMedicine/HealthneurobiologyRobotry/Artificial Intelligence
Share12Tweet8Share2ShareShareShare2

Related Posts

MD Anderson and Phoenix SENOLYTIX Forge Strategic Cross-Licensing Partnership to Advance Inducible Switch Technologies in Cell and Gene Therapies

September 5, 2025

Harnessing Good Vibrations: A New Era in Assisted Reproductive Technology

September 5, 2025

Breakthrough Discoveries from MD Anderson: Research Highlights – September 5, 2025

September 5, 2025

Skin Protein Harnesses Physical Tension to Regulate Tissue Growth

September 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

MD Anderson and Phoenix SENOLYTIX Forge Strategic Cross-Licensing Partnership to Advance Inducible Switch Technologies in Cell and Gene Therapies

Harnessing Good Vibrations: A New Era in Assisted Reproductive Technology

Breakthrough Discoveries from MD Anderson: Research Highlights – September 5, 2025

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.